Skip to content

Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)41-50
Number of pages10
JournalLancet
Volume392
Issue number10141
Early online date29 Jun 2018
DOIs
DateAccepted/In press - 31 May 2018
DateE-pub ahead of print - 29 Jun 2018
DatePublished (current) - 7 Jul 2018

Abstract

Background

The management of people with multiple chronic conditions challenges health-care systems designed around single conditions. There is international consensus that care for multimorbidity should be patient-centred, focus on quality of life, and promote self-management towards agreed goals. However, there is little evidence about the effectiveness of this approach. Our hypothesis was that the patient-centred, so-called 3D approach (based on dimensions of health, depression, and drugs) for patients with multimorbidity would improve their health-related quality of life, which is the ultimate aim of the 3D intervention.

Methods

We did this pragmatic cluster-randomised trial in general practices in England and Scotland. Practices were randomly allocated to continue usual care (17 practices) or to provide 6-monthly comprehensive 3D reviews, incorporating patient-centred strategies that reflected international consensus on best care (16 practices). Randomisation was computer-generated, stratified by area, and minimised by practice deprivation and list size. Adults with three or more chronic conditions were recruited. The primary outcome was quality of life (assessed with EQ-5D-5L) after 15 months' follow-up. Participants were not masked to group assignment, but analysis of outcomes was blinded. We analysed the primary outcome in the intention-to-treat population, with missing data being multiply imputed. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN06180958.

Findings

Between May 20, 2015, and Dec 31, 2015, we recruited 1546 patients from 33 practices and randomly assigned them to receive the intervention (n=797) or usual care (n=749). In our intention-to-treat analysis, there was no difference between trial groups in the primary outcome of quality of life (adjusted difference in mean EQ-5D-5L 0·00, 95% CI −0·02 to 0·02; p=0·93). 78 patients died, and the deaths were not considered as related to the intervention.

Interpretation

To our knowledge, this trial is the largest investigation of the international consensus about optimal management of multimorbidity. The 3D intervention did not improve patients' quality of life.

    Structured keywords

  • BRTC

Download statistics

No data available

Documents

Documents

  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via Lancet Publishing Group at https://www.sciencedirect.com/science/article/pii/S0140673618313084 . Please refer to any applicable terms of use of the publisher.

    Final published version, 356 KB, PDF-document

    Licence: CC BY

  • Supplementary information PDF

    Rights statement: This is the final published version of the article (version of record). It first appeared online via Lancet Publishing Group at https://www.sciencedirect.com/science/article/pii/S0140673618313084 . Please refer to any applicable terms of use of the publisher.

    Final published version, 257 KB, PDF-document

    Licence: CC BY

DOI

View research connections

Related faculties, schools or groups